SERMORELINE

Sermorelin is a peptide that stimulates your pituitary gland to release Human Growth Hormone (HGH). It works with the body's own ‘feedback system’. This regulates the body from producing more growth hormone than is beneficially necessary.  In addition, Sermorelin stimulates the body's own natural production of growth hormone, and does not lead to a ‘shut-down' in the body’s own natural production. If any side effects occur, they are generally mild and easily managed.   

Studies show that within one year of Sermorelin therapy, patients may experience up to 20% reduction in body fat. Most of this fat loss occurs in the abdominal fat, reduced by 30% compared with the 10% in peripheral fats (arms, legs, face and neck). While patients will notice some significant changes in the body after the first month, the full benefits are usually fully noticed after 3 to 6 months of therapy. Sermorelin is safe and easy to administer.  

• Naturally improves growth hormone production
• Increased muscle
• Increased lean body mass
• Decreased body fat
• Joint & muscle pain relief for patients with arthritis and chronic pain
• Enhanced recovery from injuries and training sessions
• Better sleep; deeper, more restful sleep
• Improved flexibility and joint health
• Enhanced overall health and wellness
• Increased levels of GH stimulate greater production of Insulin-like Growth Factor 1 (IGF-1) in the body, further driving improvements in lean body composition with accelerated growth of muscle tissue and reduced body fat
• Diminished wrinkles
• Thicker and stronger hair and nails

The most common treatment-related adverse event (occurring in about 1 patient in 6) is local injection reaction characterized by pain, swelling or redness. Of 350 patients exposed to Sermorelin in clinical trials, three discontinued therapy due to injection reactions. Other treatment-related adverse events had individual occurrence rates of less than 1% and include:                                    

• Flushing
• Dizziness
• Headache
• Flushing
• Dysphagia
• Hyperactivity
• Somnolence
• Mild pain if any at injection site immediately after administration
• Sleepiness (hence being given at night)
• Interaction with glucocorticoid (steroids)

In most cases, any side effects tend to lessen with continued use.             

• Sermorelin should not be used by women who are pregnant or breastfeeding.
• Sermorelin should not be used with untreated hypothyroidism 
• Sermorelin should not be used by individuals that are actively using corticosteroids. 

Do Not Take With the Following Medications:                                                                                                                                            

• antithyroid medications (levothyroxine)
• cyclooxygenase inhibitors (aspirin)
• glucocorticoids (prednisone)
• Insulin
• Muscarinic antagonists (atropine)
• somatostatin-containing drugs or drugs that affect somatostatin (levodopa)

Cautions:

• It should be used with caution in epilepsy and in the presence of obesity, hyperglycemia, or elevated plasma fatty acids.
• May be harmful by inhalation, ingestion, or skin absorption. May cause eye, skin, or respiratory system irritation.